Icad, Inc. operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Icad with three other
companies in this sector in the United States:
Retractable Technologies, Inc.
sales of $29.83 million
of which 100%
was Point of Care), and
CAS Medical Systems, Inc.
of which 81%
was Tisssue Oximetry Monitoring).
Icad reported sales of $26.34 million
December of 2016.
decrease of 36.6%
versus 2015, when the company's sales were $41.55 million.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Icad had sales
of $28.65 million.
Contributing to the drop in overall sales was the 58.7% decline
in Therapy, from $22.31 million to $9.21 million.
There were also decreases in sales in
Detection (down 11.0% to $17.13 million)